AN2 Therapeutics, Inc. (ANTX) vs Canton Strategic Holdings Inc (CNTN)
A side-by-side comparison of AN2 Therapeutics, Inc. and Canton Strategic Holdings Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANTX
AN2 Therapeutics, Inc.
$5.39HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
CNTN
Canton Strategic Holdings Inc
$2.34HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — ANTX vs CNTN
growth of $100 · dividends reinvested · last 5yANTX -63.6% (-18.3%/yr)CNTN -99.6% (-66.5%/yr)ANTX compounded faster over this window
Log scale — wide-divergence pair
ANTX CNTN
ANTX vs CNTN: by the numbers
- •ANTX is the larger company ($194M vs $180M market cap).
- •Both run net losses; ANTX's is the smaller (0.00% vs -6559.27% net margin).
Metrics side by side
Valuation
| Metric | ANTX | CNTN |
|---|---|---|
| P/S ratio | N/A | 120.64 |
| P/B ratio | 2.56 | 0.40 |
Profitability
| Metric | ANTX | CNTN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | -6559.27% |
| ROE | -47.78% | -21.57% |
| ROIC | -51.01% | -9.57% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.